SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cemtrex, Inc. engages in the provision of solutions in the technology industry. It operates through the following segments: Security, Industrial Services, and Cemtrex Corporate. The Security segment provides end-to-end security solutions to meet corporate, industrial, and governmental security challenges. The Industrial Services segment offers single-source expertise and services for rigging, millwrighting, in plant maintenance, equipment erection, relocation, and disassembly to diversified customers. The Cemtrex Corporate segment refers to the holding company of the other two segments. The company was founded on April 27, 1998 and is headquartered in Hauppauge, NY.

Cemtrex Inc.

Cemtrex Inc. ($CETX) is trending as traders discuss its potential for a short squeeze, drawing comparisons to recent runners like $SMX and $TWG. Community members are actively analyzing the stock's low float and high trading volume, with some expressing concerns about potential manipulation and dilution. Bullish investors are urging others to hold firm, anticipating a significant move in after-hours trading.

Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Altimmune Inc

Altimmune ($ALT) is trending as investors anticipate upcoming 48-week data, with some expecting positive results and a potential buyout. Discussions revolve around the significance of the data, especially regarding fibrosis improvement, and the impact of the recent FDA qualification of PathAI's AI-based histology tool for MASH trials. The community is also actively debating the company's leadership change and potential catalysts.

Top Wealth Group Holding Ltd. operates as a holding company, which provides caviar and caviar-based gourmet products. It focuses on supplying sturgeon caviar to customers under its own brand, Imperial Cristal Caviar. The company was founded by Kim Kwan Kings Wong on February 1, 2023 and is headquartered in Hong Kong.

Top Wealth Group Holding Ltd. - Ordinary Shares - Class A

Top Wealth Group Holding Ltd.

TWG is trending due to significant price action and high trading volume, reminiscent of other recent low-float runners. Community discussions revolve around its potential for continued gains, with some cautioning about pump-and-dump schemes and the volatility associated with Chinese stocks. Traders are actively watching for breakout opportunities and setting price targets, while also weighing the risks of entering the stock at its current levels.

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. The firm's product pipeline includes Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Redwood City, CA.

Exicure Inc

XCUR is trending following positive Phase 2 trial results for its drug burixafor, used in multiple myeloma treatment, driving excitement among investors. The community is discussing the potential for a significant squeeze due to the stock's small float and signs of short-term breakout potential, with some mentioning past runs and comparing it to other low-float stocks.

Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ.

Carvana Co. - Ordinary Shares - Class A

Carvana Co.

Carvana is trending as it's set to join the S&P 500, driving a surge in price and triggering debate about its valuation. The community is discussing whether this inclusion is justified, given concerns about the company's financials and business model, with some viewing it as a potential short opportunity while others anticipate further gains due to index fund buying.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

NFLX is trending amidst uncertainty surrounding its deal with Warner Bros. Discovery, with investors weighing the potential benefits and risks after a competing offer emerged. Community discussions revolve around the likelihood of the deal closing, potential regulatory hurdles involving Trump, and whether NFLX will increase its offer or walk away, possibly collecting a termination fee.

SAIHEAT Ltd. engages in the operation of cryptocurrency mining. It operates Bitcoin for its own account and provides full suite of services, purchase of mining machines, hosting service, and mining pool. The company was founded by Risheng Li on February 2, 2021, and is headquartered in Singapore.

SAIHEAT Ltd. - Ordinary Shares - Class A

SAIHEAT Ltd

SAIH is trending due to its low float and potential for a squeeze, with traders drawing comparisons to recent high-flying stocks like $CETX and $TWG. Community members are highlighting the stock's potential for a breakout, citing stacked bids and anticipation of shorts covering. Some are pointing to its potential in nuclear power and AI as additional catalysts, while others are mentioning its prior moves in after-hours trading.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences (WVE) is trending due to a significant surge following positive Phase 1 data for its obesity drug, WVE-007. The community is discussing the potential for a large offering given the stock's massive gains and the company's need for funding, with some traders anticipating a pullback while others remain bullish on the drug's prospects.

Litecoin is a peer-to-peer cryptocurrency created by Charlie Lee. It was created based on the Bitcoin protocol but differs in terms of the hashing algorithm used. Litecoin uses the memory intensive Scrypt proof of work mining algorithm. Scrypt allows consumer-grade hardware such as GPU to mine those coins.  Why Litecoin? Litecoin is a cryptocurrency that has evolved from Bitcoin after its own popularity in the industry, this alternative, or ‘altcoin’ has emerged to allow investors to diversify their digital currency package, according to Investopedia. Litecoin is one of the most prominent altcoins and was created by former Google employee and Director of Engineering at Coinbase, Charlie Lee. Litecoin was the first to alter Bitcoin and the most significant difference is that it takes 2.5 minutes for Litecoin to generate a block, or transaction, in comparison to Bitcoin's 10 minutes.  ‘While this matters little to traders, miners who use hardware to run Bitcoin's network cannot switch over to Litecoin. This keeps bigger mining conglomerates away from Litecoin because they cannot easily optimize their profits by swapping to another coin, contributing to a more decentralized experience. Litecoin also has bigger blocks, and more coins in circulation, making it more affordable and swift when transacting,’ Investopedia explained.  As explained above, Litecoin can transact a lot faster than Bitcoin, but there are also a number of other characteristics that investors need to know before trading. Litecoin can handle higher volumes of transactions because of the capability of transacting faster and if Bitcoin attempted to transact on the scale of its altcoin, a code update would be needed. However, Litecoin’s blocks would be larger, but with more ‘orphaned blocks'. The faster block time of litecoin reduces the risk of double spending attacks - this is theoretical in the case of both networks having the same hashing power.  Litecoin Technical Details: The transaction confirmation time taken for Litecoin is about 2.5 minutes on average (as compared to Bitcoin's 10 minutes). The Litecoin network is scheduled to cap at 84 million currency units.   Litecoin has inspired many other popular alternative currencies (eg. Dogecoin) because of its Scrypt hashing algorithm in order to prevent ASIC miners from mining those coins. However it is said that by the end of this year, Scrypt ASIC will enter the mass market.

Litecoin

Litecoin is trending as the community discusses its potential breakout against Bitcoin and anticipates a broader altcoin rally. Bullish sentiment seems to be driven by Litecoin's perceived undervaluation and historical role as digital silver, while some traders eye specific price levels as key targets. The conversation also includes potential integration with new financial infrastructures.

AlphaTime Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on September 15, 2021 and is headquartered in New York, NY.

AlphaTime Acquisition Corp

ATMC is trending due to its merger with HCYC, an Asian insurance brokerage, which is nearing completion. This SPAC's low float is fueling speculation and significant after-hours movement, with community members actively discussing potential ROI and warrant values post-merger. Some traders are pointing to previous low float runners, advising caution due to the high volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Adaptive Biotechnologies Corporation $ADPT Shares Purchased by Bosun Asset Management LLC

Bosun Asset Management LLC grew its position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 132.0% in the 2nd quarter, according to the company in its most recent filing with...

Adaptive Biotechnologies (NASDAQ:ADPT) Insider Harlan Robins Sells 10,000 Shares

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 10,000 shares of the firm's stock in a transaction on Thursday, December 4th. The shares were sold at...

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down - What's Next?

Adaptive Biotechnologies (NASDAQ:ADPT) Shares Gap Down - What's Next...

Insider Selling: Adaptive Biotechnologies (NASDAQ:ADPT) Insider Sells 27,212 Shares of Stock

Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Get Free Report) insider Harlan Robins sold 27,212 shares of the business's stock in a transaction that occurred on Wednesday, December 3rd. The...

Why Is Adaptive Biotechnologies Stock Trading Lower After Natera's Over $400 Million Deal?

Adaptive Biotechnologies shares fall as Natera's Foresight acquisition heightens MRD competition and tempers recent takeover speculation.read more...

Panagora Asset Management Inc. Invests $1.85 Million in Adaptive Biotechnologies Corporation $ADPT

Panagora Asset Management Inc. bought a new position in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) during the second quarter, according to the company in its most recent 13F...

Russell Investments Group Ltd. Increases Stake in Adaptive Biotechnologies Corporation $ADPT

Russell Investments Group Ltd. increased its stake in Adaptive Biotechnologies Corporation (NASDAQ:ADPT - Free Report) by 255.5% in the second quarter, according to its most recent 13F filing with...

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.

Current Price	$14.95
Prev Close	$14.75
Open	$14.71
Dividend Yield	0.00%
50-Day Moving Average	$16.23
Beta	1.88
Avg. Volume	2.45M
PE Ratio	-27.41

52-Week High	$20.76
52-Week Low	$5.81
Market Capitalization	$2.25B
EPS (Annual)	-$1.08
Price to Book	11.01
Revenue Per Employee	$289,106.62
Enterprise Value/EBITDA	N/A

ADPT
Adaptive Biotechnologies Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ADPT News

ADPTAdaptive Biotechnologies Corp